Pernix Therapeutics Holdings Current Ratio 2006-2018 | PTX

Pernix Therapeutics Holdings current ratio from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Pernix Therapeutics Holdings Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $0.12B $0.11B 1.08
2018-06-30 $0.07B $0.09B 0.77
2018-03-31 $0.08B $0.09B 0.88
2017-12-31 $0.09B $0.09B 0.98
2017-09-30 $0.09B $0.09B 0.99
2017-06-30 $0.08B $0.11B 0.75
2017-03-31 $0.08B $0.09B 0.88
2016-12-31 $0.11B $0.11B 0.99
2016-09-30 $0.10B $0.09B 1.08
2016-06-30 $0.11B $0.10B 1.05
2016-03-31 $0.13B $0.12B 1.07
2015-12-31 $0.16B $0.13B 1.18
2015-09-30 $0.18B $0.13B 1.38
2015-06-30 $0.18B $0.12B 1.47
2015-03-31 $0.12B $0.10B 1.21
2014-12-31 $0.12B $0.10B 1.23
2014-09-30 $0.11B $0.09B 1.23
2014-06-30 $0.12B $0.07B 1.82
2014-03-31 $0.13B $0.07B 1.87
2013-12-31 $0.08B $0.07B 1.10
2013-09-30 $0.07B $0.08B 0.90
2013-06-30 $0.07B $0.09B 0.84
2013-03-31 $0.09B $0.07B 1.36
2012-12-31 $0.10B $0.05B 1.77
2012-09-30 $0.07B $0.03B 2.68
2012-06-30 $0.08B $0.03B 3.04
2012-03-31 $0.07B $0.03B 2.24
2011-12-31 $0.07B $0.03B 2.16
2011-09-30 $0.07B $0.03B 2.47
2011-06-30 $0.04B $0.02B 1.88
2011-03-31 $0.03B $0.02B 1.80
2010-12-31 $0.03B $0.02B 1.67
2010-09-30 $0.02B $0.02B 1.32
2010-06-30 $0.02B $0.01B 1.57
2010-03-31 $0.02B $0.02B 1.61
2009-12-31 $0.01B $0.01B 1.43
2009-09-30 $0.01B $0.00B 61.06
2009-06-30 $0.01B $0.00B 64.72
2009-03-31 $0.01B $0.00B 43.21
2008-12-31 $0.01B $0.01B 1.79
2008-09-30 $0.01B $0.01B 1.81
2008-06-30 $0.01B $0.01B 1.93
2008-03-31 $0.01B $0.01B 1.91
2007-12-31 $0.00B $0.00B 0.00
2007-09-30 $0.02B $0.00B 11.48
2007-06-30 $0.06B $0.01B 4.17
2007-03-31 $0.06B $0.02B 4.29
2006-12-31 $0.00B $0.00B 0.00
2006-09-30 $0.06B $0.01B 5.12
2006-06-30 $0.07B $0.02B 3.56
2006-03-31 $0.07B $0.02B 4.74
2005-12-31 $0.00B $0.00B 0.00
2005-09-30 $0.07B $0.02B 4.34
2005-06-30 $0.07B $0.02B 4.49
2005-03-31 $0.07B $0.02B 4.33
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.017B $0.146B
Pernix Therapeutics Holdings Inc., formerly known as Golf Trust of America, Inc., is a specialty pharmaceutical company focused on developing and commercializing pharmaceutical products to meet medical needs primarily in pediatrics. The Company's product families include Aldex, Pediatex, Z-Cof, Brovex, ReZyst and QuinZyme. Its ALDEX products are indicated for the treatment of allergies and symptoms of the common cold. PEDIATEX TD is for the treatment of respiratory allergies. Z-COF 8DM is for the treatment of allergies and symptoms of the common cold. The BROVEX products are indicated for the treatment of allergies and symptoms of the common cold. REZYST IM is a chewable tablet probiotic indicated to replace active cultures that are destroyed by diet and antibiotics and to reduce symptoms associated with irritable bowel syndrome and various gastrointestinal issues. QUINZYME is a dissolve tablet for patients with depleted ubiquinone levels and for patients on statin therapy. Pernix is based in Magnolia, Texas.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $46.906B 8.33
Teva Pharmaceutical Industries (TEVA) Israel $18.283B 6.31
Mylan (MYL) United Kingdom $16.418B 6.76
Bausch Health Cos (BHC) Canada $8.901B 6.44
Dr Reddy's Laboratories (RDY) India $5.974B 23.83
Supernus Pharmaceuticals (SUPN) United States $2.043B 19.36
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.817B 3.03
Amphastar Pharmaceuticals (AMPH) United States $1.124B 121.90
Homology Medicines (FIXX) United States $0.916B 0.00
CymaBay Therapeutics (CBAY) United States $0.591B 0.00
Assembly Biosciences (ASMB) United States $0.583B 0.00
Akorn (AKRX) United States $0.557B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.414B 0.00
Voyager Therapeutics (VYGR) United States $0.349B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.288B 0.00
Sol-Gel Technologies (SLGL) Israel $0.127B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.092B 0.00
Teligent (TLGT) United States $0.087B 0.00
Acasti Pharma (ACST) Canada $0.071B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.063B 0.00
Evoke Pharma (EVOK) United States $0.053B 0.00
Agile Therapeutics (AGRX) United States $0.037B 0.00
Aevi Genomic Medicine (GNMX) United States $0.015B 0.00
China Pharma Holdings (CPHI) China $0.012B 0.00